-
Mashup Score: 0United in Choice: The Critical Role of Shared Decision-Making for Patients with Bladder Cancer - 9 hour(s) ago
Ashish M. Kamat, MD, MBBS, provides expert insights into the current state of bladder cancer care, emphasizing the critical role of patient-centric approaches and exploring the evolving treatment landscape. Kamat is an endowed professor of urologic oncology and cancer research at the University of Texas MD Anderson Cancer Center and president of the IBCG (International Bladder Cancer Group) and former president of the IBCN (International Bladder Cancer Network). Dr. Kamat has been compensated by J&J for his time to develop this content.
Source: www.urologytimes.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 276 Houston restaurants awarded one Michelin star — outpacing Dallas - 2 month(s) ago
The guessing game is over regarding where Michelin’s stars will fall: the French tire…
Source: www.houstonchronicle.comCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 35The evolving role of multidisciplinary teams in optimizing Non-Muscle Invasive bladder cancer Care. - 2 month(s) ago
Life Science Network – A web platform dedicated to life sciences.
Source: www.lifescience.netCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 35The evolving role of multidisciplinary teams in optimizing Non-Muscle Invasive bladder cancer Care. - 2 month(s) ago
Life Science Network – A web platform dedicated to life sciences.
Source: www.lifescience.netCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 8TYRA-300 shows encouraging safety, efficacy in FGFR3+ metastatic urothelial carcinoma - 3 month(s) ago
Anti-tumor activity was observed across all patients with FGFR3-altered metastatic urothelial carcinoma who were treated at the dose levels of 90 mg and higher.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 8TYRA-300 shows encouraging safety, efficacy in FGFR3+ metastatic urothelial carcinoma - 3 month(s) ago
Anti-tumor activity was observed across all patients with FGFR3-altered metastatic urothelial carcinoma who were treated at the dose levels of 90 mg and higher.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 19Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer | NEJM - 4 month(s) ago
Quick Take Video Summary from The New England Journal of Medicine — Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
Congratulations to the entire team and especially to @SWOG @slernerbcmedu1 for their leadership. Quick take here: https://t.co/TZhsq4uMxj @SvatekRob @siadaneshmand @poharkamal @ecskinner53 @AnneSchuckmanMD @montypal @adamkibel_uro @TomFlaigMD @PrimoLaraMD @DanielPetrylak… https://t.co/XhCh4ncPpf https://t.co/VtcxwCdw8E
-
-
Mashup Score: 19Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer | NEJM - 4 month(s) ago
Quick Take Video Summary from The New England Journal of Medicine — Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet-
Congratulations to the entire team and especially to @SWOG @slernerbcmedu1 for their leadership. Quick take here: https://t.co/TZhsq4uMxj @SvatekRob @siadaneshmand @poharkamal @ecskinner53 @AnneSchuckmanMD @montypal @adamkibel_uro @TomFlaigMD @PrimoLaraMD @DanielPetrylak… https://t.co/XhCh4ncPpf https://t.co/VtcxwCdw8E
-
-
Mashup Score: 29Rice student team takes top prize in national competition with innovative medical device - 4 month(s) ago
A team of Rice engineering students was awarded the top prize in a prestigious national design competition for their innovative medical device for urological care.
Source: news.rice.eduCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 2The Far-Reaching Ripple Effects of a Discredited Cancer Study - 5 month(s) ago
A flawed study attracted grants, investments and other researchers who based new work on the faulty findings.
Source: www.wsj.comCategories: General Medicine News, Hem/OncsTweet
@BladderCancerUS @PGrivasMDPhD @montypal @MaxKates @ERPlimackMD @MattGalsky @apolo_andrea @LauraBukavinaMD @SimaPorten @garysteinbergmd United in Choice: The Critical Role of Shared Decision-Making for Patients with Bladder Cancer https://t.co/eejU0qJQwb via @urologytimes @BladderCancerUS @IBCG_BladderCA @IBCN1997 @UrogerliMD @shilpaonc @PGrivasMDPhD @SpiessPhilippe @bcan_chisolm @lydiamakaroff